U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Thalidomide (marketed as Thalomid) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Thalidomide (marketed as Thalomid) Information

Thalomid (thalidomide) is a prescription medicine taken, with the medicine dexamethasone, to treat people who have been newly diagnosed with multiple myeloma. Thalomid is also used to treat people when new lesions of leprosy flare up.

Do Not Buy Thalomid (thalidomide) Over the Internet

  • You should not buy Thalomid (thalidomide) over the Internet because you will bypass important safeguards designed to protect your health (and the health of others).
  • Thalomid has special safety restrictions on how it is distributed to the public. Also, drugs purchased from foreign Internet sources are not the FDA-approved versions of the drugs, and they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities.
  • To learn more about buying drugs safely, please see Buying Prescription Medicines Online: A Consumer Safety Guide.

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Regulatory History and Labeling from Drugs@FDA

Related Information

Background Information

Back to Top